| Literature DB >> 18094545 |
So-Young Lee1, Myungshin Kim, Jihyang Lim, Yonggoo Kim, Kyungja Han, Sung Yong Kim, Hee Je Kim, In-Yang Park.
Abstract
The inv(16)(p13q22) is found in de novo AML and is closely associated with the FAB subtype M4eo. The inv(16) is rarely reported in therapy-related AML (t-AML) patients. Herein, we report a case of t-AML with inv(16) after combination chemotherapy using antimitotic agent and alkylating agent (cis-platin-paclitaxel) for ovarian serous cystadenocarcinoma.Entities:
Mesh：
Substances：
Year: 2007 PMID： 18094545 DOI： 10.3343/kjlm.2007.27.1.19
Source DB: PubMed Journal: Korean J Lab Med ISSN： 1598-6535